Nicotine might have a protective effect in the etiology of multiple sclerosis

Multiple Sclerosis Journal

Volumn 19, Issue 8, 2013, Pages 1009-1013

  Hedstrom A K ^a   Hillert, J ^b   Olsson, T ^b   Alfredsson, L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

immunology; Multiple sclerosis; snuff use

Indexed keywords

NICOTINE;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPROTECTION; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; SMOKELESS TOBACCO; SMOKING HABIT; SWEDEN;

EID: 84879767012     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512471879     Document Type: Article

References (13)

1. Filippini P, Cesario A, Fini M, et al. The yin and yang of non-neuronal alpha7 nicotinic receptors in inflammation and autoimmunity. Curr Drug Targets. 2012 ; 5: 644-655
2. Hedström AK, Bäärnhielm M, Olsson T, et al. Tobacco smoking, but not Swedish snuff usage, increases the risk of multiple sclerosis. Neurology. 2009 ; 73: 696-701
3. Carlens C, Hergens MP, Grunewald J, et al. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit Care Med. 2010 ; 181: 1217-1222
4. SMSreg. Välkommen till Svenska MS-registret, www.msreg.net (accessed 30 October 2012).
5. Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: A position paper. Ann Neurol. 2000 ; 47: 831-835 (Pubitemid 30390209)
6. Hedström AK, Åkerstedt T, Hillert J, et al. Shift work at young age is associated with increased risk for multiple sclerosis. Ann Neurol. 2011 ; 67: 110-117
7. Wingerchuk DM. Smoking: Effects on multiple sclerosis susceptibility and disease progression. Ther Adv Neurol Disord. 2012 ; 5: 13-22
8. CnattingiusSGalantiRGrafströmR. Statens folkhälsoinstitut. Hälsorisker med svenskt snus. (available at http://www.fhi.se/PageFiles/ 3094/a200515snusrapport0512yy.pdf).
9. Sopori M.. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002 ; 2: 372-377 (Pubitemid 37328760)
10. Piao WH, Campagnolo D, Dayao C, et al. Nicotine and inflammatory neurological disorders.. 2009 ; 30: 715-722
11. Ulloa L.. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov. 2005 ; 4: 673-684 (Pubitemid 41149761)
12. Nizri E, Irony-Tur-Sinai M, Lory O, et al. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol. 2009 ; 183: 6681-6688
13. De Jonge WJ, Ulloa L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol. 2007 ; 151: 915-929 (Pubitemid 47195518)